Streetbeat News

Regulatory

GOOG

GOOGL

Malaysia's Prime Minister announced a national cloud policy and AI regulations, coinciding with Google's $2 billion data center investment. This move aims to position Malaysia as a tech hub, with Google's investment expected to create 26,500 jobs and add $3 billion to Malaysia's GDP by 2030.

Portfolio Pulse from Benzinga Neuro

October 01, 2024 | 5:49 am

AMZN

GOOGL

WMT

Amazon secured a partial victory in an FTC lawsuit accusing it of maintaining illegal monopolies. The case will be split into two trials, allowing the FTC to pursue some claims. This development is part of broader antitrust scrutiny against Amazon globally.

Portfolio Pulse from Benzinga Neuro

October 01, 2024 | 1:46 am

SPRC

SciSparc Ltd. (NASDAQ:SPRC) has received FDA approval to proceed to a Phase IIb clinical trial for its Tourette Syndrome treatment, SCI-110. This marks a significant milestone in addressing unmet medical needs for TS, with the trial set to assess efficacy, safety, and tolerability in adults.

Portfolio Pulse from Rolando García

October 01, 2024 | 12:09 am

BCLI

Trading for BCLI has been halted as of 7:50:00 p.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released soon, which could impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 11:50 pm

BA

Boeing shares fell after machinists rejected a labor offer, raising concerns about operational disruptions. Additionally, the NTSB issued urgent safety recommendations for Boeing 737 rudder control systems, affecting over 40 foreign operators.

Portfolio Pulse from Vaishali Prayag

September 30, 2024 | 8:47 pm

QGEN

QIAGEN has launched the QIAcuityDx Digital PCR System for clinical oncology testing, expanding its digital PCR portfolio into clinical diagnostics. The system is 510(k) exempt in the U.S. and IVDR-certified in Europe, offering precise DNA/RNA quantitation for cancer monitoring. QIAGEN plans to expand its application menu and has partnered with pharmaceutical companies for companion diagnostics development.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:13 pm

VXRT

Vaxart has initiated a Phase 2b study to evaluate its oral COVID-19 vaccine pill, comparing it to an approved mRNA vaccine. The study is part of the U.S. government's Project NextGen, with funding up to $456 million.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:13 pm

JNJ

Johnson & Johnson has filed for FDA approval of a new treatment regimen for newly diagnosed multiple myeloma patients who are not planning a transplant. The regimen, based on the CEPHEUS study, could become a standard of care.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:11 pm

AMPG

AmpliTech Group, Inc. has received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share. This notice does not currently affect the listing or trading of the company's securities.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:08 pm

TD

The U.S. SEC has charged TD Securities in connection with a spoofing scheme. This legal action could impact the company's reputation and financial standing.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 8:03 pm